A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of bioengineered regenerative skin construct in patients with deep partial-thickness thermal burns

Authors

Angela Gibson, University of Wisconsin
James Holmes, Wake Forest University
Jeffrey Shupp, Medstar Washington Hospital
David Smith, University of South Florida
Victor Joe, University of California at Irvine
Joshua Carson, University of Florida
Jeffrey Litt, University of Missouri Health Care
Steven Kahn, Medical University of South Carolina
Tracee Short, Baton Rouge General Medical Center
Leopoldo Cancio, United States Army Institute of Surgical Research
Julie Rizzo, United States Army Institute of Surgical Research
Jeffrey E. Carter, LSUHSC New OrleansFollow
Kevin Foster, Arizona Burn Center at MIHS
B. Lynn Allen-Hoffmann, University of Wisconsin

Document Type

Article

Publication Date

5-12-2021

Publication Title

Wound Repair and Regeneration

Volume

29(3)

Comments

2021 Annual Meeting of the Wound Healing Society

Recommended Citation

Gibson, Angela; Holmes, James; Shupp, Jeffrey; Smith, David; Joe, Victor; Carson, Joshua; Litt, Jeffrey; Kahn, Steven; Short, Tracee; Cancio, Leopoldo; Rizzo, Julie; Carter, Jeffrey E.; Foster, Kevin; and Allen-Hoffmann, B. Lynn, "A phase 3 open-label, controlled, randomized trial evaluating the efficacy and safety of bioengineered regenerative skin construct in patients with deep partial-thickness thermal burns" (2021). School of Medicine Faculty Publications. 1239.
https://digitalscholar.lsuhsc.edu/som_facpubs/1239
10.1111/wrr.12921